drugset
drugset / Trial / NCT00518453

Immunogenicity of a Surface Antigen, Inactivated Influenza Vaccine Formulation 2007-2008

NCT00518453 ↗

Phase 2 Completed 129 enrolled Novartis Vaccines
Non-randomizedSingle-groupOpen-labelPrevention

Summary

Due to antigenic changes of influenza viruses, the virus strains used in influenza vaccines are adjusted every year according to WHO and CPMP recommendations. Immunogenicity and tolerability of the newly composed vaccines are subject for evaluation in a yearly clinical trial in non-elderly adults and elderly subjects (CPMP/BWP/214/96).

Timeline

Start
2007-07
Primary completion
2007-08
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluvirin Vaccine — —

Indications

influenza